BioNTech SE (BNTX) Other Non-Current Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Other Non-Current Liabilities data on file, last reported at $169.1 million in Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 9.31% year-over-year to $169.1 million; the TTM figure through Dec 2025 stood at $169.1 million (up 9.31% YoY), while the FY2025 annual figure was $164.2 million, up 6.09% from the prior year.
• Other Non-Current Liabilities declined to $169.1 million in Q4 2025, from $247.3 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $803.3 million in Q3 2024 and bottomed at $6.8 million in Q1 2021.
• A 5-year average of $338.9 million and a median of $316.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Other Non-Current Liabilities soared 25243.82% — and 2025, when it tumbled 69.22%.
• Year by year, Other Non-Current Liabilities stood at $211.5 million in 2021, then soared by 77.12% to $374.6 million in 2022, then slipped by 22.66% to $289.8 million in 2023, then sank by 46.6% to $154.7 million in 2024, then increased by 9.31% to $169.1 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $169.1 million (Q4 2025), $247.3 million (Q3 2025), and $164.8 million (Q2 2025), per Business Quant data.

Peer Comparison